Skip to content

PCOS, Insulin Resistance, and Fertility

A doctor's guide to the insulin engine behind PCOS: how it's measured, the hierarchy of treatment from diet to metformin, and why lean PCOS still counts.

Reviewed May 18, 202616 min read
By Pairceive Editorial Team /Reviewed by Dr. Rumpa
PCOS, Insulin Resistance, and Fertility

If you have a PCOS diagnosis, you have probably noticed that every conversation eventually returns to insulin. This post is the long-form version of why PCOS insulin resistance and fertility are tied together. Insulin resistance is the metabolic engine behind most PCOS, and fixing it is what unlocks ovulation for many people, whether through diet, inositol, metformin, or all three.

The short version. Insulin resistance and the resulting high circulating insulin are the central driver of the anovulation, irregular cycles, and androgen excess in most PCOS. Around half to two-thirds of people with PCOS have detectable insulin resistance, including a meaningful fraction of those with a normal BMI. The treatment hierarchy runs lifestyle first, then supplements (inositol), then medication (metformin, sometimes GLP-1), then ovulation induction (letrozole first-line). You usually combine two or three tiers; rarely is one enough.

The biology in one paragraph

Insulin's job is to move glucose from the blood into cells. In insulin resistance, the cells respond less to a given amount of insulin. The pancreas compensates by secreting more insulin, producing the high circulating insulin levels (hyperinsulinaemia) that are characteristic of PCOS.

That excess insulin does several things that matter for fertility. It acts on the ovarian theca cell to stimulate androgen (testosterone) production. It suppresses hepatic synthesis of sex hormone-binding globulin (SHBG), which raises free testosterone further. It disrupts the FSH and LH pulse patterns that drive normal follicular development.

The downstream picture is what brings most people to a PCOS workup: irregular or absent cycles, anovulation, polycystic-appearing ovaries on imaging, hirsutism, acne, and the weight pattern seen in some phenotypes. This is why insulin keeps coming back into the PCOS conversation. It is not an aside, it is the central lever. The Diamanti-Kandarakis and Dunaif review of insulin resistance and PCOS remains the cleanest summary of the mechanism.2

Lean PCOS still involves insulin resistance

This is the part of the PCOS conversation that is consistently underplayed.

Stepto and colleagues, using the gold-standard euglycaemic-hyperinsulinaemic clamp, measured insulin sensitivity in women with PCOS across BMI categories. Around 70 percent of the PCOS group had measurable insulin resistance.3 That included a meaningful fraction of women in the lean (BMI under 25) category. The 2023 PCOS guideline takes this seriously and applies the same metabolic recommendations across BMI ranges.1

The implication in clinic is simple: lean does not mean metabolically protected in PCOS. Dietary interventions, exercise, inositol, and sometimes metformin are not "only for higher-BMI PCOS." If you have lean PCOS and you have been told to come back when something is wrong, the metabolic workup and the lifestyle and supplement strategy still apply.

How insulin resistance is measured

Patients ask me which labs they should be asking for. The honest answer is a short list.

Fasting insulin

A fasting insulin above 10 to 12 mIU/L often raises suspicion of insulin resistance; below 7 is reassuring. Paired with a fasting glucose, it gives a quick read on the metabolic picture. Fasting insulin is not always in standard PCOS panels and sometimes needs to be requested specifically.

HOMA-IR

HOMA-IR is calculated from fasting glucose and fasting insulin: (fasting insulin × fasting glucose in mmol/L) / 22.5. A HOMA-IR above 2.5 is commonly used as a cutoff for insulin resistance in non-diabetic adults, with some variation by lab and population. It is a research-friendly summary number rather than a clinical decision rule, but it is useful for tracking change over time.

Oral glucose tolerance test (OGTT)

A 75 g glucose load with 2-hour glucose measurement is the gold standard for screening dysglycaemia in PCOS. The 2023 PCOS guideline recommends it in PCOS at any BMI given the elevated metabolic risk.1 Adding fasting and 2-hour insulin measurements to the OGTT (sometimes called an insulin response curve) gives additional information about the pattern of insulin secretion. The standard 2-hour glucose alone is the clinically actionable result.

In clinic, when I see PCOS labs that do not include an OGTT, the OGTT is the first thing I order, particularly if there is a personal or family history of type 2 diabetes or gestational diabetes.

HbA1c

HbA1c reflects average glucose over roughly the previous three months. It is less sensitive than the OGTT for early insulin resistance and dysglycaemia but useful for monitoring over time. An HbA1c above 42 mmol/mol (6.0 percent) deserves attention before conception; above 48 mmol/mol (6.5 percent) meets the threshold for diabetes and needs management before TTC.

What about continuous glucose monitors?

Continuous glucose monitors (CGMs) are useful for behavioural insight (seeing which specific meals spike you, watching the effect of a post-meal walk) but they do not diagnose insulin resistance. They measure interstitial glucose, not insulin, and they are not a substitute for an OGTT. If a CGM helps you make better food choices, fine. Do not skip a proper OGTT in favour of a CGM.

The PCOS insulin resistance fertility intervention hierarchy

This is the part patients usually want. The order matters.

Tier 1: Lifestyle (highest yield, free)

The 2023 PCOS guideline places lifestyle modification at the foundation of management.1

These are not lifestyle suggestions in the lifestyle-blog sense. They are first-line treatments with the most evidence behind them.

Tier 2: Supplements

The supplements with the most reasonable evidence in PCOS-associated insulin resistance:

  • Myo-inositol and D-chiro-inositol at a 40:1 ratio (typically 4 g/day myo plus 100 mg/day D-chiro), which matches the natural intracellular ratio. The Cochrane review on inositol for subfertile women with PCOS supported a modest improvement in ovulation and metabolic markers.7 See myo-inositol and PCOS for the dose and formulation detail.
  • Vitamin D repletion if deficient. Many PCOS populations have a high prevalence of vitamin D deficiency, and repletion has measurable metabolic effects. See vitamin D and fertility.
  • Adequate magnesium and zinc through diet or a quality prenatal.

Inositol is not a substitute for the lifestyle work; it is an adjunct.

Tier 3: Medication

When lifestyle and inositol are not enough, medication is the next tier.

  • Metformin, typically 1500 to 2000 mg per day in extended-release form, improves insulin sensitivity, modestly improves ovulation, and reduces the rate of gestational diabetes in PCOS pregnancies. The 2023 PCOS guideline supports metformin as an adjunct for PCOS, particularly with elevated BMI or impaired glucose tolerance.1 The Cochrane review of insulin-sensitising drugs in PCOS supports its use for improving ovulation and pregnancy rates.5
  • GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) have a growing evidence base in PCOS for weight and metabolic effects. They are not yet first-line preconception, and they should be stopped before TTC (typically at least 2 months ahead). The conversation about whether to use a GLP-1 in the pre-trying window is one to have with your endocrinologist or RE.
  • Inositol can be combined with metformin without contraindication. Some patients tolerate this combination better than metformin alone.

When I see a patient who has done the lifestyle work for three to six months and is still anovulatory, metformin is usually the next step I discuss.

Tier 4: Ovulation induction

When metabolic work has not restored ovulation and time is a factor, ovulation induction is the next layer.

  • Letrozole is the first-line ovulation induction agent in PCOS. The PALO trial (Legro and colleagues, 2014) established that letrozole produces higher live-birth rates than clomiphene in PCOS, and the 2023 PCOS guideline reflects this.4
  • Clomiphene is the second choice.
  • See the medicated-cycles section of the library for the cycle-specific detail.

The order matters. Going to ovulation induction before addressing the underlying metabolic picture is a common pattern that produces worse cycle response and more cycles needed. Fixing the engine first improves the response when you do escalate.

PCOS, Insulin Resistance, and Fertility: infographic
At a glance: PCOS, Insulin Resistance, and Fertility

What "fixing insulin first" actually means

I want to be specific about expectations, because this is where patients often feel discouraged.

Metabolic interventions are not quick. Most show measurable laboratory change at 8 to 12 weeks. Cycle change often follows lab change, sometimes with a further lag. Track menses and ovulation (BBT, OPK, mid-luteal progesterone) over 3 to 6 months before deciding whether the intervention has worked.

Combining two or three tiers is more effective than any single intervention. Diet plus inositol, or diet plus inositol plus metformin, consistently outperforms any one of those alone in the trial data.1,5,7 This is not double-counting; it is layered mechanism.

A 5 to 10 percent reduction in body weight, where weight is elevated, is the magnitude that matters in the data. You do not need to "normalise" BMI. See weight and fertility, what the numbers actually mean.

When to escalate to ovulation induction

The clinical thresholds I use, broadly:

  • Three to six months of consistent metabolic intervention without resumption of ovulation, in someone under 35.
  • Age 35 or older where time is a real factor; the threshold for escalation is shorter.
  • Other clinic-side reasons your RE recommends an earlier start (such as a known male factor, a planned IVF cycle, or a constrained funding window).

The metabolic work continues alongside the ovulation induction. It does not stop because you have moved up a tier.

What to do this week

Concrete and ordered.

  1. If you have a PCOS diagnosis and have not had metabolic labs in the last 6 to 12 months, ask for fasting insulin, fasting glucose, HbA1c, and a 75 g OGTT. Lipid panel and TSH are reasonable to include.
  2. Make one dietary change today: protein and fibre before carbohydrate at each meal. The order of food on the plate matters for postprandial insulin.
  3. Add a 20 to 30 minute walk after dinner. This is the highest-yield single behaviour change for postprandial glucose.
  4. If you are not already on inositol, start a 40:1 myo to D-chiro formulation at 4 g/day. See myo-inositol and PCOS.
  5. If your last vitamin D was below 30 ng/mL (75 nmol/L) or you have not been tested, start 1000 to 2000 IU/day pending a test.
  6. Track cycles. If you do not menstruate spontaneously for three months, that is a clinician conversation.

When to involve your clinician

  • HbA1c at or above 48 mmol/mol (6.5 percent), or OGTT in the pre-diabetes or diabetes range. These need management before, not during, TTC.
  • Persistent absence of menses for more than three months. This needs evaluation and likely a progestogen withdrawal followed by an ovulation induction plan.
  • Symptoms suggesting another diagnosis: severe hirsutism with rapid onset, signs of Cushing's syndrome, acanthosis nigricans with rapid weight changes. These warrant broader endocrine workup.
  • Pre-existing type 2 diabetes or non-alcoholic fatty liver disease. Coordinate with endocrinology or hepatology before TTC.
  • If you have already done 6 months of consistent lifestyle and supplement work without cycle change, this is the time to ask about metformin or letrozole.

The story of PCOS insulin resistance and fertility is mostly the story of insulin. If you treat the insulin picture honestly, the rest of the story is much easier to write.

What's next

Sources

  1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
  2. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews 2012;33(6):981-1030. https://doi.org/10.1210/er.2011-1034
  3. Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulinaemic clamp. Human Reproduction 2013;28(3):777-784. https://doi.org/10.1093/humrep/des463
  4. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine 2014;371(2):119-129. https://doi.org/10.1056/NEJMoa1313517
  5. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews 2012;5(5):CD003053. https://doi.org/10.1002/14651858.CD003053.pub5
  6. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility 2009;92(6):1966-1982. https://doi.org/10.1016/j.fertnstert.2008.09.018
  7. Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018;12(12):CD012378. https://doi.org/10.1002/14651858.CD012378.pub2

Common questions

Can you have insulin resistance with lean PCOS?

Yes. Using the gold-standard euglycaemic-hyperinsulinaemic clamp, around 70 percent of women with PCOS had measurable insulin resistance, including a meaningful fraction in the lean (BMI under 25) category. Lean does not mean metabolically protected in PCOS, so the dietary, exercise, inositol, and sometimes metformin strategy still applies. The 2023 PCOS guideline applies the same metabolic recommendations across BMI ranges.

Which labs should I ask for to check insulin resistance in PCOS?

A short list: fasting insulin (above 10 to 12 mIU/L raises suspicion, below 7 is reassuring), fasting glucose, HOMA-IR (above 2.5 is a common cutoff), HbA1c, and a 75 g OGTT with 2-hour glucose. The OGTT is the gold standard for screening dysglycaemia and is recommended in PCOS at any BMI. Fasting insulin is not always in standard panels and may need to be requested specifically.

What order should PCOS treatments be tried in?

The hierarchy runs lifestyle first, then supplements like inositol, then medication such as metformin or sometimes a GLP-1, then ovulation induction with letrozole as first-line. You usually combine two or three tiers, and rarely is one enough. Going to ovulation induction before addressing the underlying metabolic picture tends to produce worse cycle response and more cycles needed.

How long does it take for fixing insulin to improve PCOS cycles?

Metabolic interventions are not quick. Most show measurable laboratory change at 8 to 12 weeks, and cycle change often follows lab change, sometimes with a further lag. Track menses and ovulation using BBT, OPK, or mid-luteal progesterone over 3 to 6 months before deciding whether the intervention has worked.

When should I escalate from metabolic work to ovulation induction?

Broadly, after three to six months of consistent metabolic intervention without resumption of ovulation in someone under 35. At age 35 or older the threshold for escalation is shorter because time is a real factor. Other clinic-side reasons, such as a known male factor, a planned IVF cycle, or a constrained funding window, may justify an earlier start. The metabolic work continues alongside ovulation induction.